More Brain Bleeds With Stroke Drug in 'Real World?
BOSTON (MedPage Today) -- In a real-world practice setting, the use of tissue plasminogen activator (tPA, Alteplase) results in a higher rate of intracerebral hemorrhage than was seen in well-controlled clinical trials, researchers said here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Activase | Brain | Cardiology | Cardiovascular | Clinical Trials | Heart | Hemorrhagic Stroke | Neurology | Stroke